Chromogranin A predicts development of hormone-refractory prostate cancer

被引:0
|
作者
机构
来源
Nature Clinical Practice Urology | 2007年 / 4卷 / 11期
关键词
D O I
10.1038/ncpuro0928
中图分类号
学科分类号
摘要
引用
收藏
页码:581 / 581
相关论文
共 50 条
  • [2] Chromogranin A expression in patients with hormone naive prostate cancer predicts the development of hormone refractory disease
    Berruti, Alfredo
    Mosca, Alessandra
    Porpiglia, Francesco
    Bollito, Enrico
    Tucci, Marcello
    Vana, Federica
    Cracco, Cecilia
    Torta, Mirella
    Russo, Lucianna
    Cappia, Susanna
    Saini, Andrea
    Angeli, Alberto
    Papotti, Mauro
    Scarpa, Roberto Mario
    Dogliotti, Luigi
    [J]. JOURNAL OF UROLOGY, 2007, 178 (03): : 838 - 843
  • [3] Hormone-Refractory prostate cancer
    Rini B.I.
    Small E.J.
    [J]. Current Treatment Options in Oncology, 2002, 3 (5) : 437 - 446
  • [4] Development of Drugs Against Hormone-Refractory Prostate Cancer
    Kageyama, Yukio
    [J]. DRUG DEVELOPMENT RESEARCH, 2008, 69 (07) : 431 - 450
  • [5] SERUM CHROMOGRANIN A - A MARKER FOR HORMONE-REFRACTORY CARCINOMA OF PROSTATE - AND FOR PROGNOSIS
    Bhattacharyya, G. S.
    Singh, J. K.
    Singh, M.
    Basu, S.
    Vaid, A. K.
    Parikh, P.
    Malhotra, H.
    Babu, K. G.
    Mukherjhee, S.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 : 302 - 302
  • [6] Prognostic role of chromogranin A expression for docetaxel response in hormone-refractory metastatic prostate cancer
    Gernone, A.
    Trabucco, S.
    Troccoli, G.
    Pagliarulo, V.
    Pagliarulo, A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [7] Independent prognostic role of circulating chromogranin A in prostate cancer patients with hormone-refractory disease
    Berruti, A
    Mosca, A
    Tucci, M
    Terrone, C
    Torta, M
    Tarabuzzi, R
    Russo, L
    Cracco, C
    Bollito, E
    Scarpa, RM
    Angeli, A
    Dogliotti, L
    [J]. ENDOCRINE-RELATED CANCER, 2005, 12 (01) : 109 - 117
  • [8] Chemotherapy of the hormone-refractory prostate cancer
    Heine, K
    Wolff, JM
    [J]. AKTUELLE UROLOGIE, 2004, 35 (03) : 209 - 214
  • [9] Management of hormone-refractory prostate cancer
    Dogliotti, L
    Mosca, A
    [J]. TUMORI, 2003, : S147 - S149
  • [10] Taxanes in hormone-refractory prostate cancer
    Kang, MH
    Figg, WD
    Dahut, W
    [J]. CANCER PRACTICE, 1999, 7 (05) : 270 - 272